Genotyping of UGT1A1* 80 as an Alternative to UGT1A1* 28 Genotyping in Spain.

Pharmaceutics(2022)

引用 2|浏览8
暂无评分
摘要
Genotyping of rs887829 using the proposed method may be used to substitute genotyping of rs34983651 as a pharmacogenetics test in cancer patients prior to starting irinotecan-based treatments, mainly in the Iberian population. In addition, it is less expensive than other conventional methods and easy to implement, with a shorter time to decision than *28.
更多
查看译文
关键词
cancer,genotyping,irinotecan,personalized medicine,pharmacogenetics
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要